These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 1350332)
1. [The medical therapy of peptic ulcer. The state of the art]. Perroni GB; De Matteis G; Pellizzeri F; Cassone A; Malara F Minerva Chir; 1992 Apr; 47(7):607-12. PubMed ID: 1350332 [No Abstract] [Full Text] [Related]
2. [Concerning the discussion article by I. A. Morozov "Choice of the gastroenterologist"]. Gorshkov VA Klin Med (Mosk); 2002; 80(9):66-70. PubMed ID: 12416232 [No Abstract] [Full Text] [Related]
3. [Peptic ulcer: current therapy]. Pieragnoli E G Clin Med; 1987 Apr; 68(4):197-209. PubMed ID: 2886387 [No Abstract] [Full Text] [Related]
4. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists]. Contraşiu P; Calinici V Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):359-63. PubMed ID: 6113650 [No Abstract] [Full Text] [Related]
5. [Anti-H2 and omeprazole in brief therapy of peptic ulcer]. Piai G; Sabbatini F; Mazzacca G Ann Ital Chir; 1990; 61(1):11-4. PubMed ID: 1978622 [No Abstract] [Full Text] [Related]
6. Pharmacologic options for the control of peptic ulcer disease. Levine JB Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108 [No Abstract] [Full Text] [Related]
7. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states]. Bulgakov SA Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266 [No Abstract] [Full Text] [Related]
8. [Lansoprazol]. Ponce J; Nos P Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274 [No Abstract] [Full Text] [Related]
9. [Peptic ulcer and drug therapy]. Tsuneoka K Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):1-2. PubMed ID: 1673699 [No Abstract] [Full Text] [Related]
10. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?]. Lanas Arbeloa A; Serrano Aulló MT Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198 [No Abstract] [Full Text] [Related]
11. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists. Chelvam P; Wong EC J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478 [TBL] [Abstract][Full Text] [Related]
12. [Which drug for peptic ulcer?]. Hameeteman W; Tytgat GN Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643 [No Abstract] [Full Text] [Related]
13. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer. Florent C Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399 [TBL] [Abstract][Full Text] [Related]
14. [Histamine H2-receptor antagonists as new anti-ulcer agents]. Takemoto T Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835 [No Abstract] [Full Text] [Related]
15. [What is the role of H2 receptor blockers today in ulcer therapy?]. Creutzfeldt W Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690 [No Abstract] [Full Text] [Related]
16. Recent advances in the treatment of digestive diseases. Sun HS J Int Med Res; 1989; 17 Suppl 1():2A-8A. PubMed ID: 2566540 [TBL] [Abstract][Full Text] [Related]
19. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists]. Hentschel E Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397 [No Abstract] [Full Text] [Related]